Key Statistics
Market Cap
$598K
P/E Ratio
-0.2
EPS
$-0.65
Volume
92K
Avg Volume
—
Open
$0.39
Prev. Close
$0.42
Day Range
$0.37 - $0.46
50-Day Avg
$0.43
200-Day Avg
$0.67
52W High
$1.41
52W Low
$0.34
$0.3452-Week Range$1.41
Price Performance
1D
+1.3%
5D
+12.7%
1M
-1.0%
3M
-29.6%
6M
-46.3%
YTD
-24.6%
1Y
-51.2%
3Y
-91.3%
5Y
-99.0%
Growth Rates (YoY)
Revenue
0.0%
Net Income
18.2%
EPS
50.6%
Free Cash Flow
23.2%
FY 2025 vs FY 2024
Shares & Float
Outstanding
1.4M
Float
1.3M
Free Float
89.8%
Dividend History
Jan 14
$0.00
Oct 13
$0.00
Jul 13
$0.00
Apr 13
$0.00
Dec 12
$0.00
Oct 12
$0.00
Jul 12
$0.00
Apr 12
$0.00
Feb 12
$0.00
Nov 11
$0.00
Aug 11
$0.00
Stock Splits
1:5 · Apr 20261:5 · Mar 20261:9 · Nov 20231:9 · Nov 20231:12 · Sep 2021
Earnings Track Record
✓
Aug 24
+112.0%
✓
Nov 24
+47.8%
—
May 25
✗
May 25
-359.3%
✓
Aug 25
+24.0%
✓
Nov 25
+58.9%
✓
Feb 26
+46.1%
—
May 26
Beat estimates 8 of 12 quarters (67%)
About
XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. XORTX Therapeutics Inc. is based in Vancouver, Canada.
Latest XORTX Therapeutics Inc. News
How Much Would You Have if You Had Invested $2,000 In Apple When It Went Public?
The Motley Fool·17h ago
Tech Corner: AAPL Builds Up Tech Ecosystem
Schwab Network·18h ago
Apple's 50th Anniversary Was April 1. Is the Tech Giant's Stock Worth Buying and Holding for Another 50 Years?
The Motley Fool·21h ago
The Fed Held Rates Again: Why Long-Term Investors May Not Need to Do Anything
The Motley Fool·21h ago
Apple at 50: The iPhone maker 'blew a 5-year lead' on AI, but former insiders say it can still win
CNBC·23h ago
2,057 Shares in Apple Inc. $AAPL Acquired by Demming Financial Services Corp ADV
Defense World·1d ago
Apple Inc. $AAPL Stake Increased by Stableford Capital II LLC
Defense World·1d ago
Signal Advisors Wealth LLC Acquires 50,263 Shares of Apple Inc. $AAPL
Defense World·1d ago
Financial Summary
ExchangeNASDAQ Capital Market
CIK0001729214
ISINCA98420Q3061
CUSIP98420Q207
Market Cap$598K
Beta0.086
Employees2
Address421 – 7th Avenue SW, Vancouver
CountryCA
IPO Date2021-09-23